Recursion Pharmaceuticals Ownership | Who Owns Recursion Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Recursion Pharmaceuticals Ownership Summary

Recursion Pharmaceuticals is owned by 69.04% institutional investors, 2.31% insiders, and 28.66% retail investors. Vanguard group is the largest institutional shareholder, holding 10.56% of RXRX shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 4.05% of its assets in Recursion Pharmaceuticals shares.

RXRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Recursion Pharmaceuticals	69.04%	2.31%	28.66%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	47.19M	10.56%	$193.00M
Blackrock funding, inc. /de	50.30M	9.50%	$184.62M
Ark investment management	41.34M	7.81%	$151.71M
Blackrock	17.31M	7.33%	$129.83M
State street	34.71M	6.56%	$127.37M
Baillie gifford	23.49M	4.44%	$86.20M
Vanguard capital management	22.77M	4.30%	$83.55M
Kinnevik ab (publ)	13.43M	3.22%	$65.56M
Mubadala investment co pjsc	12.99M	3.11%	$63.37M
Geode capital management	13.82M	2.61%	$50.72M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Kinnevik ab (publ)	13.43M	100.00%	$65.56M
Dcvc opportunity fund ii gp	3.95M	84.30%	$14.50M
Data collective iv gp	5.94M	27.76%	$21.80M
Mic capital management uk llp	9.64M	8.98%	$35.39M
Novo	7.93M	2.49%	$38.70M
Nan fung group	595.29K	1.66%	$2.18M
Ark investment management	41.34M	0.98%	$151.71M
Nvidia	7.71M	0.98%	$37.61M
Carroll investors	500.35K	0.78%	$1.84M
Pivotal bioventure partners investment advisor	595.52K	0.71%	$2.19M

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	47.19M	0.00%	7.41M
Blackrock funding, inc. /de	50.30M	0.00%	7.11M
Norges bank	6.83M	0.00%	6.83M
State street	34.71M	0.00%	6.22M
Blackrock	17.31M	0.00%	4.99M

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-7.73M
Exor capital llp	2.21M	0.17%	-3.68M
Ubs asset management americas	760.13K	0.00%	-3.26M
Renaissance	-	-	-2.40M
Deerfield management company, l.p. (series c)	-	-	-2.31M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	6.83M	0.00%	6.83M	$25.08M
Sixth street partners management company	4.14M	0.00%	4.14M	$15.19M
Trexquant investment lp	228.75K	0.01%	228.75K	$1.12M
Peak6	220.00K	0.00%	220.00K	$807.40K
Soviero asset management, lp	200.00K	0.31%	200.00K	$734.00K

Sold Out

Holder	Change
Tfc financial management	-1.00
Nbc securities	-1.00
Twin peaks wealth advisors	-4.00
Financial gravity asset management	-4.00
Parallel advisors	-7.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	356	1.42%	365,404,893	8.69%	69	1.22%	185	-3.14%	98	15.29%
Mar 31, 2026	261	-24.57%	237,387,622	-26.79%	53	1.01%	147	-23.04%	60	-30.23%
Dec 31, 2025	281	-19.25%	291,943,780	-10.14%	65	1.08%	149	-16.29%	69	-14.81%
Sep 30, 2025	331	-6.76%	323,965,396	4.44%	77	1.41%	170	-3.41%	78	-8.24%
Jun 30, 2025	341	-2.01%	308,955,617	7.04%	74	1.44%	170	-16.67%	85	21.43%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	21.73M	4.05%	49.90K
ARK Disruptive Innovation Full Composite	20.67M	3.89%	-1.76M
ARK Innovation ETF	20.26M	3.78%	-194.38K
Scottish Mortgage Ord	18.17M	3.39%	-
Vanguard Morn Total Stk Mkt Idx Investor	15.83M	2.98%	105.07K
Vanguard Total Stock Mkt Idx Inv	15.83M	2.98%	105.07K
Vanguard MStar Total Stk Mkt Idx Invest	15.94M	2.97%	112.08K
ARK Genomic Revolution ETF	13.64M	2.54%	-287.30K
ARK Genomic Revolution	13.48M	2.54%	1.64M
iShares Russell 2000 ETF	12.85M	2.40%	-228.19K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 01, 2026	Borgeson Blake	-	Sell	$100.20K
Aug 04, 2026	Borgeson Blake	-	Sell	$97.50K
Jul 07, 2026	Borgeson Blake	-	Sell	$158.50K
Jun 18, 2026	Bumpus Namandje	-	Sell	$12.60K
Jun 05, 2026	Gibson Christopher	-	Sell	$144.80K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	3
2026 Q2	-	11
2026 Q1	-	11
2025 Q4	-	9
2025 Q3	-	6

RXRX Ownership FAQ

Who Owns Recursion Pharmaceuticals?

Recursion Pharmaceuticals shareholders are primarily institutional investors at 69.03%, followed by 2.31% insiders and 28.66% retail investors. The average institutional ownership in Recursion Pharmaceuticals's industry, Biotech Stocks , is 379.61%, which Recursion Pharmaceuticals falls below.

Who owns the most shares of Recursion Pharmaceuticals?

Recursion Pharmaceuticals’s largest shareholders are Vanguard group (47.19M shares, 10.56%), Blackrock funding, inc. /de (50.3M shares, 9.50%), and Ark investment management (41.34M shares, 7.81%). Together, they hold 27.87% of Recursion Pharmaceuticals’s total shares outstanding.

Does Blackrock own Recursion Pharmaceuticals?

Yes, BlackRock owns 7.33% of Recursion Pharmaceuticals, totaling 17.31M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 129.83M$. In the last quarter, BlackRock increased its holdings by 4.99M shares, a 40.49% change.

Who is Recursion Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Kinnevik ab (publ) is Recursion Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 13.43M Recursion Pharmaceuticals shares, valued at 65.56M$.

Who is the top mutual fund holder of Recursion Pharmaceuticals shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Recursion Pharmaceuticals shares, with 4.05% of its total shares outstanding invested in 21.73M Recursion Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools